Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Explore scenarios where incorporating mutual funds into an index-based portfolio can improve diversification and adaptability.
24,945 articlesEli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Leaders from the G7 unveiled a plan to shrink reliance on China for rare earths, targeting caps by 2030 and rapid mil...
Bank of America says Micron Technology is trading at a sub-10x forward multiple despite a structural shift toward AI-...
Bank of America finished the Fed stress tests without a dividend hike while peers boosted payouts. Here’s what the ba...
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
A major strategic move lands in Voyager Technologies’ lap as it closes the Astrobotic acquisition while securing a he...
A Berkshire-inspired ETF touts a 15% yield by layering a stock-picker approach with an option strategy and return of ...
Adobe faces a dynamic year as AI competition and enterprise spending shape the adobe (adbe) stock price. This report ...
Target tops Q4 earnings expectations on cost discipline while generating robust cash flow. The focus center is target...
FuelCell Energy stock just dropped after a mixed Q1 2026 report. In this analysis, we break down the what, why, and w...
A colossal DeFi trade on AAVE's swap interface left a trader facing a near $50 million loss after a mispriced swap. R...
Three durable businesses stand out for a buy-and-hold approach as markets adjust to AI-driven demand and steadier gro...